Lucent Biosciences Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.98M
- Investors
-
19
Lucent Biosciences General Information
Description
Manufacturer of crop nutrition products designed to accelerate the transition to a sustainable agri-food system. The company offers cellulose-based delivery systems, climate-positive nutrient solutions, non-polluting formulations, upcycled plant-based co-products, smart fertilizer technology, and carbon-sequestering capabilities, built for the agri-food industry to enhance crop yields through sustainable nutrient delivery and improve soil health.
Contact Information
Website
www.lucentbiosciences.comCorporate Office
- 1425 Marine Drive
- Suite 207, West Vancouver
- Vancouver, British Columbia V7T 1B9
- Canada
Corporate Office
- 1425 Marine Drive
- Suite 207, West Vancouver
- Vancouver, British Columbia V7T 1B9
- Canada
Lucent Biosciences Timeline
Lucent Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Grant | 01-Oct-2026 | $1.98M | Completed | Generating Revenue | ||
| 13. Secondary Transaction - Private | 01-Aug-2026 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 01-Jun-2026 | Completed | Generating Revenue | |||
| 11. Grant | 07-Nov-2023 | Completed | Generating Revenue | |||
| 10. Seed Round | 30-Apr-2022 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 09-Mar-2022 | Completed | Generating Revenue | |||
| 8. Seed Round | 23-Nov-2021 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-May-2021 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2021 | $4.73M | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | 01-Jan-2021 | $4.73M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Lucent Biosciences Comparisons
Industry
Financing
Details
Lucent Biosciences Competitors (4)
One of Lucent Biosciences’s 4 competitors is Verdesian Life Sciences, a Private Equity-Backed company based in Cary, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verdesian Life Sciences | Private Equity-Backed | Cary, NC | ||||
| CHS | Corporation | Inver Grove Heights, MN | ||||
| Nutrien | Corporation | Saskatoon, Canada | ||||
| Compass Minerals International | Formerly PE-Backed | Overland Park, KS |
Lucent Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lucent Biosciences Patents
Lucent Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026030829-A1 | Coatings and compositions for delivery of phosphorous and nitrogen to plants and methods of preparing same | Pending | 08-Aug-2024 | ||
| AU-2025221673-A1 | Compositions for delivery of boron to plants and methods of preparing same | Pending | 16-Feb-2024 | ||
| WO-2025171474-A1 | Compositions for delivery of boron to plants and methods of preparing same | Pending | 16-Feb-2024 | ||
| AU-2024302404-A1 | Compositions having variable hydrophobicity and coatings comprising same | Pending | 16-Jun-2023 | ||
| EP-4727907-A1 | Compositions having variable hydrophobicity and coatings comprising same | Pending | 16-Jun-2023 | C05G5/30 |
Lucent Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lucent Biosciences Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Canadian Agricultural Partnership | Other | |||
| Ontario Genomics | Accelerator/Incubator | |||
| Government of Canada | Limited Partner | |||
| Saxovent Smart Eco Investments | Corporation | Minority | ||
| Women's Equity Lab | Angel Group | Minority |
Lucent Biosciences Investments (1)
Lucent Biosciences’s most recent deal was a Joint Venture with AGT Soileos. The deal was made on 26-May-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AGT Soileos | 26-May-2022 | Joint Venture | Agricultural Chemicals |
Lucent Biosciences FAQs
-
When was Lucent Biosciences founded?
Lucent Biosciences was founded in 2014.
-
Where is Lucent Biosciences headquartered?
Lucent Biosciences is headquartered in Vancouver, Canada.
-
What is the size of Lucent Biosciences?
Lucent Biosciences has 24 total employees.
-
What industry is Lucent Biosciences in?
Lucent Biosciences’s primary industry is Agricultural Chemicals.
-
Is Lucent Biosciences a private or public company?
Lucent Biosciences is a Private company.
-
What is Lucent Biosciences’s current revenue?
The current revenue for Lucent Biosciences is .
-
How much funding has Lucent Biosciences raised over time?
Lucent Biosciences has raised $15.7M.
-
Who are Lucent Biosciences’s investors?
Canadian Agricultural Partnership, Ontario Genomics, Government of Canada, Saxovent Smart Eco Investments, and Women's Equity Lab are 5 of 19 investors who have invested in Lucent Biosciences.
-
Who are Lucent Biosciences’s competitors?
Verdesian Life Sciences, CHS, Nutrien, and Compass Minerals International are competitors of Lucent Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
